23andMe Holding Co. (ME)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about 23andMe Holding Co. (ME)
Go deeper and ask any question about ME
Company Performance
Current Price
as of Sep 13, 2024$0.34
P/E Ratio
N/A
Market Cap
$115.43M
Description
23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in South San Francisco, CA.
Metrics
Overview
- HQSouth San Francisco, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerME
- Price$0.34+4.49%
Trading Information
- Market Cap$115.43M
- Float58.88%
- Average Daily Volume (1m)2,414,376
- Average Daily Volume (3m)3,243,519
- EPS-$1.31
Company
- Revenue$199.19M
- Rev Growth (1yr)-33.60%
- Net Income-$69.40M
- Gross Margin36.44%
- EBITDA Margin-163.73%
- EBITDA-$66.17M
- EV$96.69M
- EV/Revenue0.49
- P/EN/A
- P/S0.85